Phase I clinical trial of VSN16R, announced

If it's on your mind and it has to do with multiple sclerosis in any way, post it here.

Phase I clinical trial of VSN16R, announced

Postby MSUK » Mon Nov 04, 2013 3:53 am

Phase I clinical trial of VSN16R, a potential treatment for spasticity in MS, announced

Canbex Therapeutics Ltd announced today that it has commenced a Phase I clinical trial to assess the safety and tolerability in humans of VSN16R, its novel, orally active lead compound aimed at treating spasticity in people with multiple sclerosis.

The first-in-man study of VSN16R will enrol a total of 72 healthy volunteers in a placebo-controlled, single ascending dose and multiple ascending dose design. The study is being carried out by Quintiles, the world’s leading clinical research organisation...... Read More -
User avatar
Family Elder
Posts: 2453
Joined: Wed Oct 14, 2009 3:00 pm


Return to General Discussion


  • Related topics
    Last post

Who is online

Users browsing this forum: No registered users

Contact us | Terms of Service